APA (7th ed.) Citation

N, I., H, G., I, M., O, L., C, M., C, B., . . . A, V. (2024). HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique. BMC infectious diseases, 24(1), 748. https://doi.org/10.1186/s12879-024-09579-4

Chicago Style (17th ed.) Citation

N, Ismael, et al. "HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance Before Tenofovir/ /lamivudine /dolutegravir (TLD) Roll-out in Mozambique." BMC Infectious Diseases 24, no. 1 (2024): 748. https://doi.org/10.1186/s12879-024-09579-4.

MLA (9th ed.) Citation

N, Ismael, et al. "HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance Before Tenofovir/ /lamivudine /dolutegravir (TLD) Roll-out in Mozambique." BMC Infectious Diseases, vol. 24, no. 1, 2024, p. 748, https://doi.org/10.1186/s12879-024-09579-4.